Start the conversation
It's a medical-tech company that Michael Robinson and I have both recommended to our trading service subscribers. And its focus on heart-monitoring sensors prompted us to nickname it "Cardio Corp."
The firm's stock is up 46% since we first told you about it back in September 2015. That includes the 9.4% gain the stock reaped Monday after the popular newspaper Investor's Business Dailysaid the shares had pierced a technical "breakout" point - meaning they are now a "Buy."
We always love it when a stock we've already recommended - and you've already reaped a big profit from - suddenly starts receiving "Buy" recommendations from media folks like IBD, or from the financial pros on Wall Street.
We love it because it usually means that you're already hefty profit is destined to get even bigger.
And it looks like that's just what's going to happen with "Cardio Corp."
This is premium content for Private Briefing subscribers only.